TWC
CAI

TD Waterhouse Canada’s Caris Life Sciences CAI Stock Holding History

TD Waterhouse Canada’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.63K Sell
300
-14,000
-98% -$251K ﹤0.01% 1952
2026
Q1 		$273K Sell
14,300
-78,353
-85% -$1.71M ﹤0.01% 968
2025
Q4 		$2.5M Buy
+92,653
New +$2.61M 0.02% 413

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

TD Waterhouse Canada's CAI Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Caris Life Sciences (CAI) stake by 98% in Q2 2026, selling an estimated $251K and leaving 300 shares worth $5.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

TD Waterhouse Canada first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.5M in Q4 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • TD Waterhouse Canada held 300 shares of Caris Life Sciences worth $5.63K as of Q2 2026.
  • TD Waterhouse Canada sold 14,000 Caris Life Sciences shares in Q2 2026, an estimated $251K.
  • Caris Life Sciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1952 holding.
  • TD Waterhouse Canada first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • TD Waterhouse Canada's Caris Life Sciences position peaked at $2.5M in Q4 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.